Author

Nasar Ata

Henry Ford Health

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioinformatics· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 2 Organism:human· 2 Approach:statistical model· 2 Assay:bulk RNA-seq· 1 Assay:metabolomics· 1

Frequent Co-Authors

Mirela CerghetiD· 2 shared Ramandeep RattaniD· 2 shared Shailendra GiriiD· 2 shared Faraz RashidiD· 1 shared Indrani DattaiD· 1 shared Insha ZahooriD· 1 shared Joshua S MytychiD· 1 shared Laila PoissoniD· 1 shared

Activity by Year

2024-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Mirela CerghetORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Longitudinal and stability-aware analysis reveals treatment-specific microRNA response signatures following immune-reconstitution and B-cell-targeted therapies in multiple sclerosis

Nasar Ata, Joshua S Mytych, Mirela Cerghet, Ramandeep Rattan, Sumit Govil, Shailendra Giri, Yang Mao‐Draayer

This study identifies treatment-specific miRNA response signatures in RRMS patients following cladribine or ocrelizumab, revealing distinct molecular programs associated with each therapy.

International Journal of Molecular Sciences · May 29, 2026Peer-reviewedImmunology

Utility of an untargeted metabolomics approach using a 2D GC-GC-MS platform to distinguish relapsing and progressive multiple sclerosis

Indrani Datta, Insha Zahoor, Nasar Ata, Faraz Rashid, Mirela Cerghet, Ramandeep Rattan, Laila Poisson, Shailendra Giri

This study uses untargeted metabolomics to identify altered serum metabolites distinguishing relapsing-remitting MS, progressive MS, and healthy subjects.

Metabolites · Sep 11, 2024Peer-reviewedBioinformatics